Immunovant Inc (IMVT) Insider Trading
- $410,491,065.28
- $17,375,251.18
- April 23, 2025
- Peter Salzmann
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
April 23, 2025 | Insider | 2,349 | $14.79 | Sell | $34,741.71 | |
April 23, 2025 | CTO | 1,925 | $14.79 | Sell | $28,470.75 | |
April 16, 2025 | CEO | 8,321 | $14.89 | Sell | $123,899.69 | |
April 16, 2025 | CFO | 2,993 | $14.89 | Sell | $44,565.77 | |
April 9, 2025 | CEO | 28,094 | $12.99 | Sell | $364,941.06 | |
March 7, 2025 | Director | 8,000 | $19.60 | Sell | $156,800.00 | |
Jan. 22, 2025 | CTO | 2,195 | $23.59 | Sell | $51,780.05 | |
Jan. 22, 2025 | Insider | 2,657 | $23.59 | Sell | $62,678.63 | |
Jan. 15, 2025 | Insider | 2,383 | $23.83 | Sell | $56,786.89 | |
Jan. 15, 2025 | CEO | 8,767 | $23.83 | Sell | $208,917.61 | |
Jan. 15, 2025 | CFO | 2,298 | $23.83 | Sell | $54,761.34 | |
Jan. 13, 2025 | Director | 16,845,010 | $20.00 | Buy | $336,900,200.00 | |
Jan. 8, 2025 | CFO | 4,105 | $24.10 | Sell | $98,930.50 | |
Jan. 8, 2025 | CEO | 5,105 | $24.10 | Sell | $123,030.50 | |
Nov. 20, 2024 | CEO | 16,692 | $25.45 | Sell | $424,811.40 | |
Nov. 20, 2024 | CFO | 4,174 | $25.45 | Sell | $106,228.30 | |
Nov. 20, 2024 | Insider | 3,650 | $25.45 | Sell | $92,892.50 | |
Oct. 23, 2024 | CTO | 2,740 | $29.53 | Sell | $80,912.20 | |
Oct. 23, 2024 | Insider | 4,361 | $29.53 | Sell | $128,780.33 | |
Oct. 16, 2024 | CFO | 3,271 | $28.79 | Sell | $94,172.09 | |
Oct. 16, 2024 | CEO | 9,095 | $28.79 | Sell | $261,845.05 | |
Oct. 16, 2024 | Insider | 3,188 | $28.79 | Sell | $91,782.52 | |
Oct. 9, 2024 | CEO | 4,460 | $29.56 | Sell | $131,837.60 | |
Oct. 9, 2024 | CFO | 5,162 | $29.56 | Sell | $152,588.72 | |
July 24, 2024 | Insider | 3,456 | $27.76 | Sell | $95,938.56 | |
July 24, 2024 | CTO | 2,813 | $27.76 | Sell | $78,088.88 | |
July 17, 2024 | CFO | 3,123 | $29.69 | Sell | $92,721.87 | |
July 17, 2024 | Insider | 2,505 | $29.69 | Sell | $74,373.45 | |
July 17, 2024 | CEO | 8,685 | $29.69 | Sell | $257,857.65 | |
July 9, 2024 | Insider | 1,527 | $28.06 | Sell | $42,847.62 | |
July 9, 2024 | CFO | 4,747 | $28.06 | Sell | $133,200.82 | |
July 9, 2024 | CEO | 4,619 | $28.06 | Sell | $129,609.14 | |
May 22, 2024 | CEO | 16,163 | $29.65 | Sell | $479,232.95 | |
May 22, 2024 | Insider | 3,247 | $29.65 | Sell | $96,273.55 | |
May 22, 2024 | CFO | 4,042 | $29.65 | Sell | $119,845.30 | |
April 24, 2024 | CTO | 7,239 | $28.90 | Sell | $209,207.10 | |
April 24, 2024 | Insider | 3,261 | $28.90 | Sell | $94,242.90 | |
April 17, 2024 | CFO | 12,253 | $29.06 | Sell | $356,072.18 | |
April 17, 2024 | Insider | 10,115 | $29.06 | Sell | $293,941.90 | |
April 17, 2024 | CEO | 34,079 | $29.06 | Sell | $990,335.74 | |
April 9, 2024 | CFO | 3,689 | $31.18 | Sell | $115,023.02 | |
April 9, 2024 | Insider | 1,053 | $31.18 | Sell | $32,832.54 | |
April 9, 2024 | CEO | 4,807 | $31.18 | Sell | $149,882.26 | |
Feb. 22, 2024 | CFO | 2,930 | $36.15 | Sell | $105,919.50 | |
Feb. 22, 2024 | Insider | 2,134 | $36.15 | Sell | $77,144.10 | |
Jan. 26, 2024 | Insider | 3,027 | $37.92 | Sell | $114,783.84 | |
Jan. 18, 2024 | Insider | 424 | $41.03 | Sell | $17,396.72 | |
Jan. 11, 2024 | CFO | 3,515 | $41.83 | Sell | $147,032.45 | |
Jan. 5, 2024 | CEO | 3,824 | $38.59 | Sell | $147,568.16 | |
Jan. 5, 2024 | Insider | 1,297 | $38.59 | Sell | $50,051.23 |
Insiders are both buying and selling Immunovant Inc stock.
The insider traders at Immunovant Inc are: Peter Salzmann, Eva Renee Barnett, Julia G Butchko, William L Macias, Mark S Levine, Jay S Stout, Michael Geffner, Sciences Ltd. Roivant, Frank Torti, Andrew J Fromkin, Douglas J Hughes, Atul Pande, and George V Migausky
The most active insider trader at Immunovant Inc is Peter Salzmann with 29 trades.
Peter Salzmann has sold the most Immunovant Inc stock with a total value of $10,663,512.89.
Sciences Ltd. Roivant has bought the most Immunovant Inc stock with a total value of $746,840,410.00.
The most recent insider trade for Immunovant Inc was on April 23, 2025.
The single biggest insider buy for Immunovant Inc was from Sciences Ltd. Roivant with a total value of $336,900,200.00 on Jan. 13, 2025.
The single biggest insider sell for Immunovant Inc was from Peter Salzmann with a total value of $2,207,502.36 on Aug. 14, 2023.